Rhumbline Advisers Vista Gen Therapeutics, Inc. Transaction History

Rhumbline Advisers

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$0.12 - $0.3 $1,927 - $4,818	16,060 Added 6.62%	258,749 $32,000
Q4 2022 Feb 14, 2023	BUY	$0.09 - $4.8 $374 - $19,992	4,165 Added 1.75%	242,689 $25,000
Q3 2022 Nov 10, 2022	BUY	$0.14 - $4.8 $2,343 - $80,352	16,740 Added 7.55%	238,524 $36,000
Q2 2022 Aug 11, 2022	BUY	$0.88 - $1.73 $25,434 - $50,002	28,903 Added 14.98%	221,784 $195,000
Q1 2022 May 12, 2022	BUY	$1.14 - $2.09 $40,875 - $74,939	35,856 Added 22.83%	192,881 $239,000
Q4 2021 Feb 10, 2022	SELL	$1.67 - $2.76 $5,377 - $8,887	-3,220 Reduced 2.01%	157,025 $306,000
Q3 2021 Nov 12, 2021	BUY	$2.62 - $3.45 $46,132 - $60,747	17,608 Added 12.34%	160,245 $439,000
Q2 2021 Aug 05, 2021	BUY	$1.96 - $3.15 $279,568 - $449,306	142,637 New	142,637 $449,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $610M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.